Does Rallies summarize ONMD news?

Yes. Rallies summarizes ONMD news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.

Is ONMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ONMD. It does not provide personalized investment advice.

ONMD (OneMedNet Corp Class A Common Stock) Stock Analysis - News

OneMedNet Corp Class A Common Stock (ONMD) is a publicly traded Healthcare sector company. As of May 21, 2026, ONMD trades at $0.91 with a market cap of $46.05M and a P/E ratio of -14.15. ONMD moved +13.61% today. Year to date, ONMD is -28.50%; over the trailing twelve months it is +112.82%. Its 52-week range spans $0.30 to $4.22. Rallies surfaces ONMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in ONMD news today?

OneMedNet Launches Palantir-Powered iRWD Platform Serving 80M Patients, Secures Two Subscriptions: OneMedNet’s iRWD platform on Palantir Foundry now offers searchable access to 251 million studies across 80 million patient journeys, a ~70% network increase and linkage to 47 million tokenized patients via Datavant. The company has secured two new iRWD subscriptions and aims to convert its expanding pipeline into ARR opportunities.

ONMD Key Metrics

Key financial metrics for ONMD
Metric	Value
Price	$0.91
Market Cap	$46.05M
P/E Ratio	-14.15
EPS	$-0.06
Dividend Yield	0.00%
52-Week High	$4.22
52-Week Low	$0.30
Volume	525
Avg Volume	0
Revenue (TTM)	$1.36M
Net Income	$-2.80M
Gross Margin	-37.01%

Latest ONMD News

OneMedNet Launches Palantir-Powered iRWD Platform Serving 80M Patients, Secures Two Subscriptions — Apr 22, 2026
OneMedNet Sees 329% RWD Revenue Growth to $1.25M, Liabilities Cut 74% — Apr 6, 2026
OneMedNet Partners with Inka Health on Pilot to Fuel PNKP Inhibitor Development Using AI — Apr 1, 2026
OneMedNet Integrates Navidence CODefs to Streamline RWD Cohorts, Tap $1.88B Market — Mar 18, 2026
OneMedNet Secures Multi-Year Deals Worth Millions with RWD Platform Expansion — Feb 27, 2026

Recent ONMD Insider Trades

Kosasa Thomas bought 268.82K (~$250.00K) on May 18, 2026.
Kosasa Thomas bought 280.90K (~$250.00K) on Apr 23, 2026.
Yu Jeffrey bought 903.61K (~$750.00K) on Apr 1, 2026.

ONMD Analyst Consensus

ONMD analyst coverage data. Average price target: $0.00.

Common questions about ONMD

What changed in ONMD news today?: OneMedNet Launches Palantir-Powered iRWD Platform Serving 80M Patients, Secures Two Subscriptions: OneMedNet’s iRWD platform on Palantir Foundry now offers searchable access to 251 million studies across 80 million patient journeys, a ~70% network increase and linkage to 47 million tokenized patients via Datavant. The company has secured two new iRWD subscriptions and aims to convert its expanding pipeline into ARR opportunities.
Does Rallies summarize ONMD news?: Yes. Rallies summarizes ONMD news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is ONMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ONMD. It does not provide personalized investment advice.